Fig. 5
From: Research-based findings on scope of liposome-based cosmeceuticals: an updated review
A Photograph of a patient who showed a good response to the treatment with the 4‐n‐butylresorcinol and resveratrol (RSV) cream. B Lesional and non-lesional melanin index (MI) during the 4‐week treatment with the 4‐n‐butylresorcinol and RSV cream. The lesional MI at weeks 2 and 4 were significantly decreased compared with the baseline. The non-lesional MI showed no significant change throughout the study (*P < 0.05). C Mean IGA score during the treatment. Reprinted under permission from John Wiley and Sons [39]